EBV latency III immortalization program sensitizes B cells to induction of CD95-mediated apoptosis via LMP1: role of NF- B, STAT1, and p53

Autor: Georg W. Bornkamm, Jean Feuillard, Ibtissam Youlyouz-Marfak, Christophe Le Clorennec, Eric Adriaenssens, Jean Coll
Přispěvatelé: Physiologie Moléculaire de la Réponse Immune et des Lymphoproliférations (PMRIL), Université de Limoges (UNILIM)-Génomique, Environnement, Immunité, Santé, Thérapeutique (GEIST FR CNRS 3503)-Centre National de la Recherche Scientifique (CNRS), Institut de biologie de Lille - IBL (IBLI), Université de Lille, Sciences et Technologies-Institut Pasteur de Lille, Réseau International des Instituts Pasteur (RIIP)-Réseau International des Instituts Pasteur (RIIP)-Centre National de la Recherche Scientifique (CNRS)-Université de Lille, Droit et Santé, Université de Limoges (UNILIM)
Rok vydání: 2006
Předmět:
MESH: Signal Transduction
Epstein-Barr Virus Infections
Herpesvirus 4
Human

MESH: I-kappa B Proteins
T-Lymphocytes
MESH: Membrane Glycoproteins
MESH: NF-kappa B
Apoptosis
MESH: Estrogens
Biochemistry
chemistry.chemical_compound
NF-KappaB Inhibitor alpha
MESH: Genetic Vectors
hemic and lymphatic diseases
MESH: Animals
MESH: Interferon-Stimulated Gene Factor 3
STAT1
MESH: Tumor Suppressor Protein p53
Genes
Dominant

B-Lymphocytes
Membrane Glycoproteins
MESH: Epstein-Barr Virus Infections
biology
NF-kappa B
[SDV.MHEP.HEM]Life Sciences [q-bio]/Human health and pathology/Hematology
hemic and immune systems
MESH: Tumor Necrosis Factors
Interferon-Stimulated Gene Factor 3
Hematology
Transfection
Fas receptor
MESH: Gene Expression Regulation
MESH: Antigens
CD95

Cell biology
MESH: Cell Transformation
Viral

Tumor Necrosis Factors
I-kappa B Proteins
MESH: Epstein-Barr Virus Nuclear Antigens
Plasmids
Signal Transduction
MESH: Mutation
MESH: Cell Line
Tumor

Fas Ligand Protein
Genetic Vectors
Immunology
Virus
Viral Matrix Proteins
Viral Proteins
Immune system
MESH: Plasmids
MESH: B-Lymphocytes
Cell Line
Tumor

otorhinolaryngologic diseases
Animals
Humans
fas Receptor
MESH: Viral Matrix Proteins
MESH: Humans
MESH: Apoptosis
MESH: Herpesvirus 4
Human

Estrogens
NF-κB
Cell Biology
Cell Transformation
Viral

MESH: Viral Proteins
MESH: Fas Ligand Protein
IκBα
MESH: T-Lymphocytes
Epstein-Barr Virus Nuclear Antigens
Gene Expression Regulation
chemistry
Mutation
biology.protein
Cancer research
Tumor Suppressor Protein p53
MESH: Genes
Dominant
Zdroj: Blood
Blood, American Society of Hematology, 2006, 107 (5), pp.2070-8. ⟨10.1182/blood-2005-05-2053⟩
ISSN: 1528-0020
0006-4971
Popis: Epstein-Barr virus (EBV) induces CD95 expression and the CD95 gene (FAS) is regulated by NF-kappaB, STAT1, and/or p53. To understand the contribution of these factors in the regulation of CD95 by EBV in lymphoblastoid cell lines (LCLs), we cloned dominant-active IkappaBalpha, active (STAT1alpha) and inactive (STAT1beta) forms of STAT1, p53, a dominant-negative mutant of LMP1, and wild-type LMP1 into a novel double-inducible episomal vector, pRT-1. These plasmids were stably transfected either into wild-type LCLs or EREB2-5 cells, an LCL with an estrogen-regulatable EBNA2 protein. Inhibition of LMP1 signaling decreased expression of CD95, whereas overexpression of LMP1 markedly increased it. Induction of the latency III program in EREB2-5 cells correlated with activation of NF-kappaB, STAT1, and p53. CD95 expression was regulated by these 3 transcriptional systems. STAT1 and p53 activation were secondary to NF-kappaB activation. CD95 surface expression sensitized EBV-infected B cells to the induction of CD95-mediated apoptosis. In vitro inhibition of CD95-CD95 ligand interaction was found to reverse T-cell killing of EBV-infected B cells. Therefore, LMP1 activation of NF-kappaB sensitizes infected B cells to CD95-mediated apoptosis and renders EBV latency III-immortalized B cells susceptible to elimination by the immune system, contributing to the establishment of a host/virus equilibrium.
Databáze: OpenAIRE